VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $891,000 | +21.9% | 36,300 | 0.0% | 0.11% | +26.2% |
| Q2 2016 | $731,000 | -23.5% | 36,300 | 0.0% | 0.08% | -23.6% |
| Q1 2016 | $955,000 | -74.1% | 36,300 | 0.0% | 0.11% | -78.2% |
| Q4 2015 | $3,690,000 | +359.5% | 36,300 | +706.7% | 0.50% | +276.1% |
| Q3 2015 | $803,000 | -23.1% | 4,500 | -4.3% | 0.13% | -14.1% |
| Q2 2015 | $1,044,000 | +11.8% | 4,700 | 0.0% | 0.16% | +17.3% |
| Q1 2015 | $934,000 | +37.6% | 4,700 | 0.0% | 0.13% | +40.0% |
| Q4 2014 | $679,000 | +10.0% | 4,700 | 0.0% | 0.10% | +4.4% |
| Q3 2014 | $617,000 | +4.0% | 4,700 | 0.0% | 0.09% | +5.8% |
| Q2 2014 | $593,000 | -4.4% | 4,700 | 0.0% | 0.09% | +13.2% |
| Q1 2014 | $620,000 | – | 4,700 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |